{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:27:13Z","timestamp":1776749233199,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jaip.2016.06.019","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T18:54:19Z","timestamp":1469213659000},"page":"41-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sublingual Immunotherapy for the Polyallergic Patient"],"prefix":"10.1016","volume":"5","author":[{"given":"Amber N.","family":"Pepper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mois\u00e9s A.","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Casale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.06.019_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.iac.2015.08.005","article-title":"Subcutaneous immunotherapy and sublingual immunotherapy: comparative efficacy, current and potential indications, and warnings\u2014United States versus Europe","volume":"36","author":"Nelson","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2016.06.019_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-015-0109-6","article-title":"Management of the polyallergic patient with allergy immunotherapy: a practice-based approach","volume":"12","author":"Demoly","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaci.2011.11.019","article-title":"Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence","volume":"129","author":"Calder\u00f3n","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2500\/aap.2015.36.3830","article-title":"Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT)","volume":"36","author":"Tabatabaian","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2016.06.019_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1081-1206(10)60259-1","article-title":"Comparison of allergen immunotherapy practice patterns in the United States and Europe","volume":"103","author":"Cox","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib6","series-title":"GRASTEK (timothy grass pollen allergen extract) tablet for sublingual use [package insert]","year":"2014"},{"key":"10.1016\/j.jaip.2016.06.019_bib7","series-title":"ORALAIR (sweet vernal, orchard, perennial rye, timothy, and Kentucky blue grass mixed pollens allergen extract) tablet for sublingual use [package insert]","year":"2014"},{"key":"10.1016\/j.jaip.2016.06.019_bib8","series-title":"RAGWITEK (short ragweed pollen allergen extract) tablet for sublingual use [package insert]","year":"2014"},{"key":"10.1016\/j.jaip.2016.06.019_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaci.2015.06.046","article-title":"Sublingual grass and ragweed immunotherapy: clinical considerations\u2014a PRACTALL consensus report","volume":"137","author":"Li","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2013.2049","article-title":"Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review","volume":"309","author":"Lin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2016.06.019_bib11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2016.06.019_bib12","unstructured":"ALK. ALK obtains European approval for its house dust mite sublingual allergy immunotherapy tablet against allergic rhinitis and allergic asthma. August 31, 2015. Available at: http:\/\/ir.alk-abello.com\/releasedetail.cfm?releaseid=929348. Accessed June 6,\u00a02016."},{"key":"10.1016\/j.jaip.2016.06.019_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-015-0061-z","article-title":"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis","volume":"5","author":"Demoly","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2016.06.019_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/039463201002300227","article-title":"The POLISMAIL lesson: sublingual immunotherapy may be prescribed also in polysensitized patients","volume":"23","author":"Ciprandi","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2016.06.019_bib16","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1185\/03007995.2015.1094653","article-title":"Optimum treatment strategies for polyallergic patients\u2014analysis of a large observational trial","volume":"31","author":"Shah-Hosseini","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2016.06.019_bib17","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2016.4078","article-title":"New horizons in allergen immunotherapy","volume":"315","author":"Wood","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2016.06.019_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaip.2015.09.013","article-title":"Molecular allergen-specific IgE assays as a complement to allergen extract-based sensitization assessment","volume":"3","author":"Aalberse","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaip.2015.08.016","article-title":"Serological IgE analyses in the diagnostic algorithm for allergic disease","volume":"3","author":"Hamilton","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaip.2015.08.002","article-title":"Clinical history-driven diagnosis of allergic diseases: utilizing in\u00a0vitro IgE testing","volume":"3","author":"Adkinson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-6-1","article-title":"Panallergens and their impact on the allergic patient","volume":"6","author":"Hauser","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib22","first-page":"371","article-title":"Amaranthaceae pollens: review of an emerging allergy in the Mediterranean area","volume":"24","author":"Villalba","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaip.2015.11.004","article-title":"Sequential treatment initiation with timothy grass and ragweed sublingual immunotherapy tablets followed by simultaneous treatment is well tolerated","volume":"4","author":"Maloney","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1081-1206(10)60718-1","article-title":"Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients","volume":"98","author":"Marogna","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib25","first-page":"399","article-title":"Efficacy and quality of life with once-daily sublingual immunotherapy with grasses plus olive pollen extract without updosing","volume":"17","author":"Moreno-Ancillo","year":"2007","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2009.04.037","article-title":"Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract","volume":"124","author":"Amar","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaip.2014.09.018","article-title":"Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy","volume":"3","author":"Nelson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/1744666X.2016.1102058","article-title":"Efficacy and safety of sublingual immunotherapy in children","volume":"12","author":"Arasi","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2015.12.1298","article-title":"Sublingual or subcutaneous immunotherapy for allergic rhinitis?","volume":"137","author":"Durham","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.061","article-title":"Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: pooled analyses","volume":"138","author":"Durham","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib31","first-page":"CD011293","article-title":"Sublingual immunotherapy for asthma","volume":"28","author":"Normansell","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2016.06.019_bib32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaci.2013.02.013","article-title":"Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison","volume":"131","author":"Dretzke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2012.08.012","article-title":"Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison","volume":"130","author":"Di Bona","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaip.2013.04.005","article-title":"Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review","volume":"1","author":"Chelladurai","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib37","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2014.01.030","article-title":"Esophageal hypereosinophilia induced by grass sublingual immunotherapy","volume":"133","author":"Antico","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000355161","article-title":"Induction of eosinophilic esophagitis by sublingual pollen immunotherapy","volume":"7","author":"Miehlke","year":"2013","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.jaip.2016.06.019_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.12560","article-title":"Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma","volume":"70","author":"Maloney","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.019_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1398-9995.2006.01301.x","article-title":"Anaphylaxis to multiple pollen allergen sublingual immunotherapy","volume":"62","author":"Eifan","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.019_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaip.2014.03.015","article-title":"Clinical case of anaphylaxis with sublingual immunotherapy: house dust mite allergen","volume":"2","author":"Van Dyken","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.06.019_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2011.02761.x","article-title":"Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile","volume":"67","author":"Calderon","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.019_bib43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib44","doi-asserted-by":"crossref","first-page":"AB281","DOI":"10.1016\/j.jaci.2014.12.1857","article-title":"Epinephrine use in clinical trials of sublingual immunotherapy tablets for treatment of allergic rhinitis with\/without conjunctivitis","volume":"135","author":"Maloney","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib45","doi-asserted-by":"crossref","DOI":"10.3310\/hta17270","article-title":"A\u00a0systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis","volume":"17","author":"Meadows","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaip.2016.06.019_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaci.2015.12.1300","article-title":"International consensus on allergen immunotherapy, II: mechanisms, standardization, and pharmacoeconomics","volume":"137","author":"Jutel","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOO.0000000000000150","article-title":"Allergy immunotherapy in reducing healthcare cost","volume":"23","author":"Cox","year":"2015","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2016.06.019_bib48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study","volume":"126","author":"Marogna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1081-1206(10)60211-6","article-title":"Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study","volume":"101","author":"Marogna","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","article-title":"Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis","volume":"114","author":"Novembre","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.019_bib52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816302628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816302628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:11:45Z","timestamp":1761973905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219816302628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213219816302628"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.06.019","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual Immunotherapy for the Polyallergic Patient","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}